Borstkankerpreventie

Bronnen en Literatuur

Literatuur

• Blanks RG, Moss SM, Patnick J.Results from the UK NHS breast screening programme 1994-1999. J Med Screen 2000; 7: 195-198.
• Broeders MJM, Scharpantgen A, Ascunce N, Gairard B, Olsen AH, Mantellini P, et al.Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989–2000. Eur J Cancer Prev, 2005; 14: 107-16.
• CBO, Kwaliteitsinstituut voor de Gezondheidszorg.Richtlijn screening en diagnostiek van het mammacarcinoom. Utrecht: CBO, 2007a.
• Ford D, Easton DF, Peto J.Estimate of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57: 1457-1462.
• Fracheboud J, Koning HJ de.Vergelijking analoge en digitale screeningsperformance van drie digitale pilots in het Nederlandse bevolkingsonderzoek naar borstkanker; eindverslag. Rotterdam: Erasmus Medisch Centrum, 2007.
• Gabe R, Duffy SW.Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol, 2005; 16(2): iii153-62.
• Gezondheidsraad.Wet bevolkingsonderzoek: de toetsing van vergunningsaanvragen. Den Haag: Gezondheidsraad, 1996b.
• Gezondheidsraad.Het nut van bevolkingsonderzoek naar borstkanker. Den Haag: Gezondheidsraad, 2002a; 03.
• Giard RWM, Coeberg JWW, Wijnen JA.Tegenvallende effectiviteit van bevolkingsonderzoek naar baarmoederhalskanker. Ned Tijdschr Geneeskd 1997; 141: 317-321.
• Gøtzsche P, Olsen O.Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 129-134.
• Groenewoud JH, Otten JDM, Fracheboud J, Draisma G, Ineveld BM van, Holland R, et al. Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands. Breast Cancer Res Treat,2007; 102: 211-8.
• Koning HJ de, Boer R, Warmerdam PG, Beemsterboer PMM, Maas PJ van der.Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 1995; 87: 1217-23.
• Koning HJ de, Coebergh JWW, Dongen JA van.Is mass screening for breast cancer cost-effective? Eur J Cancer 1996; 32A: 1835-44.
• LETB, Landelijk Evaluatie Team voor bevolkingsonderzoek naar Borstkanker.Landelijke Evaluatie van bevolkingsonderzoek naar borstkanker; 11e rapport. Rotterdam: Erasmus Medisch Centrum, 2005.
• LETB, Landelijk Evaluatie Team voor bevolkingsonderzoek naar Borstkanker.Tussenrapportage 2007. Rotterdam: Erasmus Medisch Centrum, 2007.
• Lynge E, Olsen AH, Fracheboud J, Patnick J.Reporting of performance indicators of mammography screening in Europe. Eur. J. Cancer Prev., 2003; 12: 213-222.
• Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al.Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’follow-up: a randomised controlled trial. Lancet, 2006; 368: 2053-60.
• Nab HW.Trends in incidence and prognosis in female breast cancer since 1955. Thesis. Rotterdam: Erasmus Universiteit Rotterdam, 1995.
• Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE.Long-term effects of mammography screening: updated overview of the Swedish randomised trails. Lancet 2002; 359: 909-919.
• Nyström L, Rutqvist LE, Wall S, et al.Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973-8.
• Olsen O, Gøtzsche PC.Screening for breast cancer with mammography (Cochrane review). In: The Cochrane Library, 1. Oxford: Update Software, 2002.
• Olsen O, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al.Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ, 2005a; 305(7485): 220.
• Otto SJ et al.Initiation of population-based mammography screening in Dutch municipalities and effect on breast cancer mortality: a systematic review. Lancet, 2003; 361: 1411-7.
• Perry N, Broeders M, Wolf C de, Törnberg S, Holland R, Karsa L von.European guidelines for quality assurance in breast cancer screening and diagnosis. Luxembourg: EC, 2006a.
• Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al.Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med, 2005; 353: 1773-83.
• Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, et al.Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat, 2008; 108: 409-16.
• Shapiro S, Coleman EA, Broeders M.Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998; 27: 735-42.
• Vervoort MM, Draisma G, Fracheboud J, Poll-Franse LV van de, Koning HJ de.Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer, 2004; 91: 242-7.
• Witte K, Berg M van den, Bovendeur I. Screening. In: Wilk EA van der, Melse JM, Broeder JM den, Achterberg PW (eindred.). Leren van de buren. Beleid publieke gezondheid internationaal bezien: roken, alcohol, overgewicht, depressie, gezondheidsachterstanden, jeugd, screening. RIVM-rapport nr. Houten: Bohn Stafleu Van Loghum,2007.